CO213 Combination of Targeted Therapy with Chemotherapy (T+C) Versus Chemotherapy Alone (C) As a First Line (1L) Treatment in Patients with Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review and Meta-Analysis

S Varukolu,R Pandey,P Pandey

doi:10.1016/j.jval.2023.03.2438

CO213 Combination of Targeted Therapy with Chemotherapy (T+C) Versus Chemotherapy Alone (C) As a First Line (1L) Treatment in Patients with Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review and Meta-Analysis

S Varukolu, R Pandey + Show 1 more

https://doi.org/10.1016/j.jval.2023.03.2438

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Publication Date: Jun 1, 2023

Affiliation: PAREXEL International (India)

#Esophageal Squamous Cell Carcinoma #Esophageal Squamous Cell Carcinoma Cases + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ESCC is ranked seventh by incidence rate and sixth by mortality rate among all cancers. In 2020, there were around 604,000 new ESCC cases and approximately 544,000 deaths, globally. In this meta-analysis, we compared the efficacy of 1L T+C vs C in ESCC.

Full Text